medigraphic.com
ISSN 1561-302X (Print)

2023, Number 1

<< Back Next >>

Rev cubana med 2023; 62 (1)

Ozone therapy and cancer: myth or reality

Alonso DT, Reyes RE, Cuétara LE

Language: Spanish
References: 43
Page: 1-13
PDF size: 507.99 Kb.


ABSTRACT

Introduction: The clinical use of ozone therapy is increasing every day worldwide and it covers different medical specialties, including oncology. However, in Cuba, the investigations that evaluate the use of ozone therapy in cancer patients are scarce, so scientific studies are needed to demonstrate its clinical efficacy.
Objective: To explain the pharmacological and biochemical mechanisms of ozone therapy and its use in cancer as a complementary therapy.
Methods: Databases available through Infomed Network were consulted. Key words used were cancer, ozone therapy and oxidative stress. Original and systematic review articles from the last ten years that evaluated the use of ozone therapy in the treatment of cancer were selected.
Results: Cancer is, as such, a disease that induces oxidative stress. Ozone therapy supports its use as an adjuvant therapy through oxidative pre-conditioning that stimulates the cell's antioxidant systems against the action of free radicals. Thus, it is possible to neutralize the harmful action of oxidative stress. Ozone increases the efficacy of radio-chemotherapy and helps reducing the side effects of these treatments by activating the cell's antioxidant systems. Ozone therapy is characterized by the simplicity of its application, low costs, high effectiveness and with practically no side effects, compared to other adjuvant treatments.
Conclusions: The use of ozone therapy in oncology as an adjuvant therapy represented a therapeutic resource of great value given its effectiveness and safety profile. Its use could be extended to improve tissue oxygenation and thus enhance the efficacy of radiochemotherapy, reducing side effects and improving the patients’s quality of life.


REFERENCES

  1. Schwartz A, Martínez-Sánchez G. La ozonoterapia y su fundamentación científica. Revista Española de Ozonoterapia. 2012 [acceso 26/01/2021];2(1):163-98. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=39159171.

  2. Smith NL, Wilson AL, Gandhi J, Vatsia S, Khan SA. Ozone therapy: an overview of pharmacodynamics, current research, and clinical utility. Med Gas Res. 2017 [acceso 12/02/2021];7(3):212-9. Disponible en: https://pubmed.ncbi.nlm.nih.gov/29152215/2.

  3. Baeza-Noci J, Pinto-Bonilla R. Systemic Review: Ozone: A Potential New Chemotherapy. Int J Mol Sci. 2021 [acceso 01/02/2021];22(21):11796. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34769225/3.

  4. Gil del Valle L, Guerra MMD, Carballo-Reyes AL, Márquez JAS, López OE, Fernández FFB, et al. Observancia de reacciones adversas y análisis de cumplimiento de bioseguridad en la aplicación rectal de ozonoterapia en pacientes cubanos con infección aguda o convalecientes de COVID-19. J Pharm Pharmacogn Res. 2021 [acceso 22/01/2021];9(4):465-73. Disponible en: https://www.researchgate.net/publication/3500443394.

  5. Carreras SAU, Aleaga LA, Guerrero ER, Fiallo MÁ. Uso de ozonoterapia en las pacientes con enfermedad inflamatoria pélvica aguda Etapa III. Rev Cuban Obstet Ginecol. 2019 [acceso 16/01/2021];45(3):e480. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_abstract&pid=S0138-600X20190003000055.

  6. AES. Anuario Estadístico de Salud 2019. Dirección de Registros Médicos y Estadísticas de Salud del Ministerio de Salud Pública de Cuba. ed 48. La Habana: 2020. [acceso 03/03/2021]. Disponible en: https://temas.sld.cu/estadisticassalud/2020/05/13/publicado-el-anuario-estadistico-de-salud-2019/6.

  7. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021 [acceso 16/01/2021];71:209-49. Disponible en: https://acsjournals.onlinelibrary.wiley.com/action/showCitFormats?doi=10.3322%2Fcaac.216607.

  8. Carballo LC, Hernández AA, Frías SH. Ozonoterapia sistémica mediante la insuflación rectal aplicada a pacientes con cáncer óseo. Convención Internacional de Salud, Cuba Salud. 2018. [acceso 06/02/2021] Disponible en: http://www.convencionsalud2018.sld.cu/index.php/connvencionsalud/2018/paper/viewFile/1022/10718.

  9. Diaz TA, Reyes ER, González JC, Carrasco JM. Estrés oxidativo, terapia antioxidante y cáncer. Rev Cuban de Oncol. 2021 [acceso 12/01/2021];19(2):e_117. Disponible en: https://revoncologia.sld.cu/index.php/onc/article/view/1179.

  10. Luongo M, Brigida AL, Mascolo L, Gaudino G. Possible therapeutic effects of ozone mixture on hypoxia in tumor development. Anticancer Res. 2017 [acceso 29/01/2021];37(2):425-35. Disponible en: https://pubmed.ncbi.nlm.nih.gov/28179287/10.

  11. Clavo B, Santana-Rodríguez N, Llontop P, Gutiérrez D, Suárez G, López L, et al. Ozone therapy as adjuvant for cancer treatment: is further research warranted? Evid Based Complement Alternat Med. 2018 [acceso 26/01/2021];2018:7931849. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30271455/11.

  12. Aboelella NS, Brandle C, Kim T, Ding Z-C, Zhou G. Oxidative Stress in the Tumor Microenvironment and Its Relevance to Cancer Immunotherapy. Cancers. 2021 [acceso 18/02/2021];13(5):986. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956301/12.

  13. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011 Mar 4 [acceso 12/01/2021];144(5):646-74. Disponible en: https://pubmed.ncbi.nlm.nih.gov/21376230/13.

  14. Semenza GL. Hypoxia-inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype. EMBO J. 2017 [acceso 15/01/2021];36(3):252-9. Disponible en: https://pubmed.ncbi.nlm.nih.gov/28007895/14.

  15. Pavlova NN, Thompson CB. The emerging hallmarks of cancer metabolism. Cell metab. 2016 [acceso 11/01/2021];23(1):27-47. Disponible en: https://pubmed.ncbi.nlm.nih.gov/26771115/15.

  16. Vaupel P, Multhoff G. Fatal alliance of hypoxia-/HIF-1a-driven microenvironmental traits promoting cancer progression. Adv Exp Med Biol. 2020 [acceso 14/01/2021];1232:169-76. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31893407/16.

  17. Pezzuto A, Carico E. Role of HIF-1 in cancer progression: novel insights. A review. Curr Mol Med. 2018 [acceso 21/01/2021];18(6):343-51. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30411685/17.

  18. Zhang J, Duan D, Song ZL, Liu T, Hou Y, Fang J. Small molecules regulating reactive oxygen species homeostasis for cancer therapy. Med Res Rev. 2021 [acceso 27/01/2021];41(1):342-94. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32981100/18.

  19. Re L, Martínez-Sánchez G, Bordicchia M, Malcangi G, Pocognoli A, Morales-Segura MA, et al. Is ozone pre-conditioning effect linked to Nrf2/EpRE activation pathway in vivo? A preliminary result. Eur J Pharmacol. 2014 [acceso 11/01/2021];742:158-62. Disponible en: https://pubmed.ncbi.nlm.nih.gov/25218903/19.

  20. León Jd, Pareja A. Inmunología del cáncer II: bases moleculares y celulares de la carcinogénesis. Horiz Med. 2019 [acceso 25/01/2021];19(2):84-92. Disponible en: http://www.scielo.org.pe/scielo.php?pid=S1727-558X2019000200011&script=sci_abstract20.

  21. Fernández-Cuadros ME, Pérez-Moro O, Albaladejo-Florin M, Álava-Rabasa S. El ozono intrarticular modula la inflamación, mejora el dolor, la rigidez, la función y tiene un efecto anabólico sobre la artrosis de rodilla: estudio cuasiexperimental prospectivo tipo antes-después, 115 pacientes. Rev Soc Esp Dolor. 2020 [acceso 21/02/2021];27(2):78-88. Disponible en: https://scielo.isciii.es/scielo.php?script=sci_abstract&pid=S1134-8046202000020000521.

  22. Parascandolo A, Laukkanen MO. Carcinogenesis and reactive oxygen species signaling: Interaction of the NADPH oxidase NOX1-5 and superoxide dismutase 1-3 signal transduction pathways. Antioxid Redox Signal. 2019 [acceso 27/01/2021];30(3):443-86. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393772/22.

  23. Huang R, Zhou P-K. HIF-1 signaling: A key orchestrator of cancer radioresistance. Radiation Medicine and Protection. 2020;1(2020):7-14. DOI: https://mednexus.org/doi/10.1016/j.radmp.2020.01.006

  24. Kim JH, Jenrow KA, Brown SL. Mechanisms of radiation-induced normal tissue toxicity and implications for future clinical trials. Radiat Oncol J. 2014 [acceso 17/01/2021];32(3):103-15. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194292/24.

  25. Mavragani IV, Laskaratou DA, Frey B, Candéias SM, Gaipl US, Lumniczky K, et al. Key mechanisms involved in ionizing radiation-induced systemic effects. A current review. Toxicol Res (Camb). 2015 [acceso 16/01/2021];5(1):12-33. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061884/25.

  26. Pettersen EO, Ebbesen P, Gieling RG, Williams KJ, Dubois L, Lambin P, et al. Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium. J Enzyme Inhib Med Chem. 2015 [acceso 12/01/2021];30(5):689-721. Disponible en: https://pubmed.ncbi.nlm.nih.gov/25347767/26.

  27. Perillo B, Di Donato M, Pezone A, Di Zazzo E, Giovannelli P, Galasso G, et al. ROS in cancer therapy: the bright side of the moon. Exp Mol Med. 2020 [acceso 13/01/2021];52(2):192-203. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32060354/27.

  28. Sánchez-Muniz FJ, Culebras JM, Vicente-Vacas L. JONNPR y las investigaciones realizadas en el camino al Premio Nobel 2019. Una visión personal sobre las moléculas y los aspectos moleculares y mecanismos de control subyacentes relacionados con la hipoxia y el cáncer. JONNPR. 2020 [acceso 27/01/2021];5(3):246-58. Disponible en: https://revistas.proeditio.com/jonnpr/article/view/345228.

  29. Jiang H, Wang H, De Ridder M. Targeting antioxidant enzymes as a radiosensitizing strategy. Cancer Lett. 2018 [acceso 24/01/2021];438:154-64. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30223069/29.

  30. Wang H, Jiang H, Van De Gucht M, De Ridder M. Hypoxic radioresistance: can ROS be the key to overcome it? Cancers (Basel). 2019 [acceso 12/02/2021];11(1):112. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30669417/30.

  31. Martinez-Outschoorn UE, Peiris-Pagés M, Pestell RG, Sotgia F, Lisanti MP. Cancer metabolism: a therapeutic perspective. Nat Rev Clin Oncol. 2017 [acceso 07/02/2021];14(1):11-31. Disponible en: https://pubmed.ncbi.nlm.nih.gov/27141887/31.

  32. Rodionova OG, Gusareva MA, Voshedskiy VI, Vasilyeva EO, Sheiko EA, Solntseva AA, et al. Ozone therapy as accompanying treatment for chemoradiotherapy in patients with locally advanced cervical cancer. Journal of Clinical Oncology. 2021;39:15-suppl,e17515. DOI: https://ascopubs.org/doi/abs/10.1200/JCO.2021.39.15_suppl.e1751532.

  33. Klaunig JE, Wang Z. Oxidative stress in carcinogenesis. Current Opinion in Toxicology. 2018 [acceso 22/01/2021];7:116-21. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S246820201730150X33.

  34. Choudhury R. Hypoxia and hyperbaric oxygen therapy: a review. Int J Gen Med. 2018 [acceso 13/02/2021];11:431-42. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30538529/34.

  35. Iyikesici MS. Survival outcomes of metabolically supported chemotherapy combined with ketogenic diet, hyperthermia, and hyperbaric oxygen therapy in advanced gastric cancer. Niger J Clin Pract. 2020 [acceso 10/02/2021];23(5):734-40. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32367884/35.

  36. Bennett MH, Feldmeier J, Smee R, Milross C. Hyperbaric oxygenation for tumour sensitisation to radiotherapy. Cochrane Database Syst Rev. 2012 [acceso 11/01/2021];2012(4):CD005007. Disponible en: https://pubmed.ncbi.nlm.nih.gov/22513926/36.

  37. Schwartz A, Sanchez G, Sabah F. Declaración de Madrid sobre la ozonoterapia. Edición 2. Madrid: ISCO3; 2015. Disponible en: https://aepromo.org/declaracion-de-madrid-sobre-la-ozonoterapia-en-seis-idiomas-isco3-2a-ed-2015-50-paginas/37.

  38. Re L, Rowen R, Travagli V. Ozone therapy and its use in medicine: further comments. Cardiology. 2017 [acceso 23/01/2021];136(4):269. Disponible en: https://www.karger.com/Article/Abstract/45261838.

  39. (AEPROMO) AEdPMeO. Declaration on Ozone Therapy. Edición 3. Madrid: ISCO3; 2020 [acceso 23/01/2021]. Disponible en: Disponible en: https://aepromo.org/en/madrid-declaration-on-ozone-therapy-isco3-3rd-edition-2020-103-pages/ 39.

  40. Machín González V, Turrent Figueras J, Menéndez Cepero S, Hernández Díaz A. Ozonoterapia y laserpuntura en el tratamiento de la sordera súbita. Rev Cuban Cir. 2004 [acceso 26/01/2021];43:3-4. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-7493200400030000140.

  41. Norma GG, Yunier TT, Rosa del Carmen VA, Cristina GF, Leonela Cristina GF, editors. Eficacia de la magnetoterapia combinada con ozonoterapia en pacientes con hernia discal. Segundo Congreso Virtual de Ciencias Básicas Biomédicas en Granma. Manzanillo. 2021 [acceso 30/01/2021]. Disponible en: https://docplayer.es/220933336-Eficacia-de-la-magnetoterapia-combinada-con-ozonoterapia-en-pacientes-con-hernia-discal.html41.

  42. Solano Pérez M, Maldonado Chávez M, Benítez Rodriguez G, Vistel Montoya D, González Moreno E. Efectividad de la ozonopuntura en pacientes con artrosis cervical. MEDISAN. 2020 [acceso 21/02/2021];24(5):760-77. Disponible en: https://medisan.sld.cu/index.php/san/article/view/2964/207642.

  43. Zanardi I, Borrelli E, Valacchi G, Travagli V, Bocci V. Ozone: a multifaceted molecule with unexpected therapeutic activity. Curr Med Chem. 2016




2020     |     www.medigraphic.com